Von Hippel-Lindau Disease: all 35 studies
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Study of HS-10516 in Patients With VHL Syndrome Associated TumorsRecruitingNCT06553339Phase 1
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT06523582
- Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell CarcinomaRecruitingNCT06391879
- Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule CellsRecruitingNCT06194669
- A Study of BPI-452080 in Subjects With Solid TumorsNot yet recruitingNCT05843305Phase 1
- 68Ga-NY104 PET/CT in Von Hippel-Lindau DiseaseRecruitingNCT05810246Phase 2
- Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesRecruitingNCT05534854
- Propranolol and Von Hippel-Lindau DiseaseRecruitingNCT05424016Not applicable
- MyVHL: Patient Natural History StudyRecruitingNCT03749980
- Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) PatientsRecruitingNCT02420067
- Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel LindauCompletedNCT03907657Phase 2Results posted
- MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)CompletedNCT03108066Phase 2Results posted
- A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabCompletedNCT02859441Phase 1/2Results posted
- Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine TumorsCompletedNCT01967537Phase 2Results posted
- Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau SyndromeCompletedNCT01436227Phase 2Results posted
- TKI 258 in Von Hippel-Lindau Syndrome (VHL)TerminatedNCT01266070Phase 2Results posted
- Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau SyndromeTerminatedNCT00673816Phase 1/2Results posted
- Phase II Study of Vandetanib in Individuals With Kidney CancerCompletedNCT00566995Phase 2Results posted
- Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminatedNCT00330564Phase 2Results posted
- 17AAG to Treat Kidney Tumors in Von Hippel-Lindau DiseaseCompletedNCT00088374Phase 2Results posted
- Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau DiseaseCompletedNCT00062166Results posted
- MSD Belzutifan PASWithdrawnNCT06554730
- 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedNCT03001349Early Phase 1
- Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?Status unknownNCT02207686
- Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)CompletedNCT02108002Phase 1
- Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) DiseaseCompletedNCT01168440Phase 2
- Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau DiseaseTerminatedNCT01015300Early Phase 1
- Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau DiseaseCompletedNCT00970970
- Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1/2
- Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00089765Phase 1
- Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau SyndromeCompletedNCT00075348
- EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00056199Phase 1
- Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
- Von Hippel-Lindau Disease Genetic Epidemiology StudyTerminatedNCT00001803
- Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668